StockData
UroGen Pharma Ltd. logo

UroGen Pharma Ltd. (URGN) stock

URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$27.65−4.08 (-12.86%)

Close on Nov 20, 2026Market cap $1.35BP/E –Yield –

UroGen Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

UroGen Pharma's price to book ratio was 18.2× on Jan 31, 2025, against 6.8× a year earlier. Over the last 5 years it ranged from 2.1× to 23.3×, with a median of 5.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 202518.2×+0.6
2024Dec 31, 202417.6×−1.2
2022Apr 29, 202218.9×+12.1
2021Dec 31, 20216.8×+3.5
2020Dec 31, 20203.3×−0.0
2019Dec 31, 20193.3×−3.4
2018Dec 31, 20186.7×+1.4
2017Dec 29, 20175.3×–

More UroGen Pharma figures

See a number that looks wrong?